Adrenal cortex autoantibodies in subjects with normal adrenal function.

Area of Science:

• Immunology
• Endocrinology
• Autoimmune Diseases

Background:

• Autoimmune Addison's disease (Autoimmune AD) is a chronic condition with a prolonged preclinical phase.
• This phase is characterized by the presence of adrenal cortex autoantibodies (ACAs).
• Understanding the natural history and risk factors for Autoimmune AD is crucial for early detection and management.

Purpose of the Study:

• To analyze key data regarding the natural history and risk factors of Autoimmune AD.
• To identify reliable markers for detecting individuals at high risk for developing Autoimmune AD.
• To develop a model for calculating future Autoimmune AD risk based on identified parameters.

Main Methods:

• Analysis of populations at high risk, including relatives of patients and those with other autoimmune conditions.
• Detection of risk markers using immunofluorescence tests for ACAs and radioimmunoassay for 21-hydroxylase autoantibodies (21-OHAbs).
• Evaluation of adrenal cortex function through basal hormone levels and ACTH stimulation tests.
• Multivariate analysis of genetic, demographic, antibody, and functional factors.

Main Results:

• High-risk populations include first relatives and patients with chronic hypoparathyroidism or premature ovarian failure.
• ACAs and 21-OHAbs are effective markers for identifying at-risk individuals.
• Multivariate analysis identified high antibody titers, chronic hypoparathyroidism, chronic candidiasis, and adrenal dysfunction as significant predictors of future Autoimmune AD.
• An equation model was developed to calculate future Autoimmune AD risk.

Conclusions:

• Risk stratification for Autoimmune AD is possible using a combination of antibody levels and clinical factors.
• Individuals with higher risk scores require more intensive monitoring.
• High-risk individuals are suitable candidates for future Autoimmune AD prevention trials.